Playtika Holding Corp.
PLTK News Today: Stay Updated with the Latest Playtika Holding Corp. News in Real Time
Find PLTK news now at Meyka AI. Stay informed with the latest Playtika Holding Corp. stocks updates, including price news, market analysis, and expert insights.
AGL.AX Stock Today, February 28: Wall St Funding Push, 14% Upside
AGL Energy share price at A$9.81 as Wall St funding talks progress. We cover AGL renewables funding, broker price targets, dividend 2026 outlook, and key ASX levels.
UWT AMEX intraday 27 Feb 2026: Trading at $0.16 on heavy 244.14M volume
UWT stock trading at $0.16 on AMEX with 244.14M shares intraday; analysis, grade, and forecast
UBXN.SW u‑blox (SIX) CHF135.00 on 27 Feb 2026: AI positioning growth suggests upside
UBXN.SW stock at CHF135.00 on 27 Feb 2026; valuation, technicals and Meyka AI forecast for investors
IM Cannabis IMCC.CN CNQ down 40% 27 Feb 2026: Oversold bounce opportunity
IMCC.CN stock plunged 40% to C$5.10 on 27 Feb 2026. Quick oversold bounce possible, model sees large upside vs current price
MBH Corporation (M8H.DE) €0.037 on 27 Feb 2026: after-hours fall tests valuation
M8H.DE stock falls to €0.037 after hours on 27 Feb 2026; thin liquidity and a steep rerating drive risks and short-term forecasts
4582.T SymBio (JPX) down 11.48% to JPY 162 pre-market 28 Feb 2026: key risk
4582.T stock falls 11.48% to JPY 162 pre-market 28 Feb 2026; analysis of drivers, metrics, Meyka AI forecast and risks
HOCHDORF HOCN.SW (SIX) CHF1.59 after hours 27 Feb 2026: oversold bounce
HOCN.SW stock after hours update: CHF1.59 price, fundamental stress and a short-term bounce setup
GNRSU The Greenrose Holding Co. (PNK) at $0.000001 on 27 Feb 2026: analyst view
GNRSU stock falls to $0.000001 on 27 Feb 2026; analysis, Meyka AI grade, and model forecast for investors
CALN.SW Stock Today: February 27 — Buyback, Margin Beat Lift Outlook
Calida stock rises as EBIT doubles to CHF 9m despite a 6.6% sales drop. A 2% buyback starts 9 March and dividend is cut to CHF 0.25. Focus shifts to a >6% EBIT-margin target and the Cosabella review.